Latent TB Testing Market by Test Type (Tuberculin Skin Test/TST, IGRA Test), Application (Household Contacts (HHC) of Tuberculosis (TB) Patients, People Living with HIV), End User (Diagnostic Labs, Hospitals), Region - Global Forecast to 2029

Latent TB Testing Market by Test Type (Tuberculin Skin Test/TST, IGRA Test), Application (Household Contacts (HHC) of Tuberculosis (TB) Patients, People Living with HIV), End User (Diagnostic Labs, Hospitals), Region - Global Forecast to 2029

The latent TB testing market will rise in value from estimated USD 582.5 million in 2024 to USD 773.4 million in 2029, at a CAGR of 5.8% over the forecast period. Increased funding and grants for TB control programs across the globe have emerged as an important growth factor in the latent TB testing market. Substantial funding is now being committed by governments and international bodies, including WHO and the Global Fund, to address the increasing burden of TB, especially in terms of early detection and prevention. These funds are being channeled into increasing access to diagnostic facilities, especially in high-burden regions where the healthcare infrastructure is generally weak. The availability of funds also encourages the training of healthcare professionals who work with a patient to accurately diagnose and properly manage cases of latent TB. Apart from that, research grants and international collaborations are also enabling TB testing integration into routine healthcare services. Thus, this growing funding is rendering latent TB tests available and enhancing the efforts to control TB globally. This, in turn, is fuelling the growth of the global latent TB testing market.

“Interferon gamma release assay (IGRA) segment is expected to have the fastest growth rate in the latent TB testing market, by test type, during the forecast period.”

The latent TB testing market is segmented into tuberculin skin test (TST) and interferon gamma release assay (IGRA), based on test type. Interferon gamma release assay (IGRA) tests are projected to account for the highest CAGR during the forecast period. One major driving factor is its higher accuracy than conventional tuberculin skin tests (TST); IGRA tests do not suffer from interference by prior BCG vaccination, which can cause false positives for TST. Thus, IGRA is preferred in populations that have high BCG vaccination coverage. Furthermore, IGRA tends to offer faster and more consistent results, meaning that patients require fewer visits, enhancing overall efficiency in testing. Growing penetration of these tests in high-risk populations, such as patients who are immunocompromised and health care workers, continue to support increased demand. Favourable regulatory approvals and recommendations by various international health bodies, including the WHO, have also helped increase their adoption. Along with such factors, rising funding for research in TB and advancements in diagnostics are also driving the high growth of the IGRA test segment in the latent TB testing market.

“Household contacts with pulmonary TB segment accounted for the highest growth rate in the latent TB testing market, by application, during the forecast period.”

Based on application, the latent TB testing market is bifurcated into household contacts (HHC) with pulmonary tuberculosis (TB)/household contacts (HHC) of tuberculosis (TB) patients, people living with HIV, and other applications. The household contacts with pulmonary TB application segment is expected to have the highest CAGR during the forecast period. Individuals in close contact with a TB patient have a much higher probability of becoming infected with latent TB, which is the reason why regular screenings are crucial in being able to diagnose the illness early and intervene by taking preventive measures. Increasing recognition of the critical role that latent TB testing plays among high-risk groups by healthcare providers and public health agencies also drives the need for accurate latent TB diagnostics. In addition, screening of contacts across the households by the governments and TB control programs in efforts to curb latent infections from becoming active TB is further driving growth in the market segment. Collectively, all these factors are contributing to the fast growth of this application within the latent TB testing market.

“Asia Pacific: The fastest-growing region in latent TB testing market.”

The worldwide market for latent TB testing is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Notably, the Asia Pacific region is anticipated to experience the most substantial growth in the forecast period. The Asia Pacific region bears a high burden of tuberculosis, such as in India and China, which record a high incidence rate and thereby drive the need for essential latent TB screening and management. Growth in government and international organization funding and campaigns against TB has also led to better access to diagnostics and healthcare infrastructure in Asia Pacific. Awareness among the communities and among healthcare workers regarding the need for early detection of latent TB has also been significantly increasing the demand for further testing. Another major growth driver of this segment in the latent TB testing market is the increasing healthcare expenditure, along with supportive regulatory frameworks. All these factors propel increased growth of the latent TB testing market in the Asia Pacific region.

The break-up of the profile of primary participants in the latent TB testing market:

By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 – 30%

By Designation: C-level - 27%, D-level - 18%, and Others - 55%

By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6%, and Middle East & Africa- 4%

The key players in this market are QIAGEN (Netherlands), Revvity (US), Beijing Wantai Biopharmaceutical Co., Ltd. (China), Sanofi (France), Endo, Inc. (US), bioMérieux (France), SD Biosensor, INC. (South Korea), Lionex GmbH (Germany), Sanofi (France), Serum Institute of India Pvt. Ltd. (India), ARKRAY, Inc. (Japan), Zhi Fei Biological (China), AID Autoimmun Diagnostika GmbH (Germany), Boditech Med Inc. (South Korea), Bioneovan Co., Ltd (China), and Biopanda Reagents Ltd (UK).

Research Coverage:

This research report categorizes the latent TB testing market by test type (tuberculin skin test (TST) and interferon gamma release assay (IGRA)), by application (household contacts with pulmonary TB, people living with HIV, and other applications), by end user (diagnostic laboratories, hospitals & clinics, academic & research institutes, and other end users), and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the latent TB testing market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. New product & service launches, and recent developments associated with the latent TB testing market. Competitive analysis of upcoming startups in the latent TB testing market ecosystem is covered in this report.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall latent TB testing market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

Analysis of key drivers (rising incidence of latent tuberculosis, widespread use of BCG vaccine, and increased funding and grants for TB control programs), opportunities (Growth opportunities in emerging economies), restraints (Unfavorable reimbursement scenario), and challenges (changing regulatory landscape and operational barriers and labor shortage) influencing the growth of the latent TB testing market.

Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the latent TB testing market.

Market Development: Comprehensive information about lucrative markets – the report analyses the latent TB testing market across varied regions.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the latent TB testing market.

Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like QIAGEN (Netherlands), Revvity (US), Beijing Wantai Biopharmaceutical Co., Ltd. (China), Sanofi (France), and Endo, Inc. (US).

Tables List

Table 1 Latent Tb Testing Market: Risk Assessment

Table 2 Commercially Available Igra Tests, By Key Player

Table 3 Average Selling Price Of Latent Tb Tests, 2022–2024

Table 4 Indicative Price Of Igra Tests, By Region, 2022–2024

Table 5 Latent Tb Testing Market: List Of Major Patents, 2022–2023

Table 6 Import Data For Diagnostic And Laboratory Reagents (Hs Code 3822), By Country, 2019–2023 (Usd Million)

Table 7 Export Data For Diagnostic And Laboratory Reagents (Hs Code 3822), By Country, 2019–2023 (Usd Million)

Table 8 Latent Tb Testing Market: Role In Ecosystem

Table 9 Latent Tb Testing Market: Porter’s Five Forces Analysis

Table 10 Influence Of Stakeholders On Buying Process Of Latent Tb Tests (%)

Table 11 Key Buying Criteria For Latent Tb Tests, By Type

Table 12 Classification Of Devices In Europe

Table 13 Japan: Time, Cost, And Complexity Of Registration Process

Table 14 Australia: Classification Of Ivd Medical Devices

Table 15 North America: Key Regulatory Bodies, Government Agencies,

And Other Organizations

Table 16 Europe: Key Regulatory Bodies, Government Agencies,

And Other Organizations

Table 17 Asia Pacific: Key Regulatory Bodies, Government Agencies,

And Other Organizations

Table 18 Latin America: Key Regulatory Bodies, Government Agencies,

And Other Organizations

Table 19 Rest Of The World: Key Regulatory Bodies, Government Agencies,

And Other Organizations

Table 20 Latent Tb Testing Market: Detailed List Of Key Conferences & Events

Table 21 Latent Tb Testing Market, By Test Type, 2022–2029 (Usd Million)

Table 22 Latent Tb Testing Market, By Test Type, 2022–2029 (In Millions)

Table 23 Bcg Vaccination Coverage, By Region, 2021 Vs 2022 Vs 2023 (%)

Table 24 Commercially Available Igra Products, By Company

Table 25 Latent Tb Testing Market For Igra, By Region, 2022–2029 (Usd Million)

Table 26 North America: Latent Tb Testing Market For Igra, By Country,

2022–2029 (Usd Million)

Table 27 Europe: Latent Tb Testing Market For Igra, By Country,

2022–2029 (Usd Million)

Table 28 Asia Pacific: Latent Tb Testing Market For Igra, By Country,

2022–2029 (Usd Million)

Table 29 Latin America: Latent Tb Testing Market For Igra, By Country,

2022–2029 (Usd Million)

Table 30 Middle East & Africa: Latent Tb Testing Market For Igra, By Country, 2022–2029 (Usd Million)

Table 31 Commercially Available Tst Products In Market, By Company

Table 32 Latent Tb Testing Market For Tst, By Region, 2022–2029 (Usd Million)

Table 33 North America: Latent Tb Testing Market For Tst, By Country,

2022–2029 (Usd Million)

Table 34 Europe: Latent Tb Testing Market For Tst, By Country,

2022–2029 (Usd Million)

Table 35 Asia Pacific: Latent Tb Testing Market For Tst, By Country,

2022–2029 (Usd Million)

Table 36 Latin America: Latent Tb Testing Market For Tst, By Country,

2022–2029 (Usd Million)

Table 37 Middle East & Africa: Latent Tb Testing Market For Tst, By Country, 2022–2029 (Usd Million)

Table 38 Latent Tb Testing Market, By Application, 2022–2029 (Usd Million)

Table 39 Latent Tb Testing Market For People Living With Hiv, By Region,

2022–2029 (Usd Million)

Table 40 North America: Latent Tb Testing Market For People Living With Hiv,

By Country, 2022–2029 (Usd Million)

Table 41 Europe: Latent Tb Testing Market For People Living With Hiv,

By Country, 2022–2029 (Usd Million)

Table 42 Asia Pacific: Latent Tb Testing Market For People Living With Hiv,

By Country, 2022–2029 (Usd Million)

Table 43 Latin America: Latent Tb Testing Market For People Living With Hiv,

By Country, 2022–2029 (Usd Million)

Table 44 Middle East & Africa: Latent Tb Testing Market For People Living With Hiv, By Country, 2022–2029 (Usd Million)

Table 45 Latent Tb Testing Market For Household Contacts With Pulmonary Tb, By Region, 2022–2029 (Usd Million)

Table 46 North America: Latent Tb Testing Market For Household Contacts With Pulmonary Tb, By Country, 2022–2029 (Usd Million)

Table 47 Europe: Latent Tb Testing Market For Household Contacts With Pulmonary Tb, By Country, 2022–2029 (Usd Million)

Table 48 Asia Pacific: Latent Tb Testing Market For Household Contacts With Pulmonary Tb, By Country, 2022–2029 (Usd Million)

Table 49 Latin America: Latent Tb Testing Market For Household Contacts With Pulmonary Tb, By Country, 2022–2029 (Usd Million)

Table 50 Middle East & Africa: Latent Tb Testing Market For Household Contacts With Pulmonary Tb, By Country, 2022–2029 (Usd Million)

Table 51 Latent Tb Testing Market For Other Applications, By Region,

2022–2029 (Usd Million)

Table 52 North America: Latent Tb Testing Market For Other Applications,

By Country, 2022–2029 (Usd Million)

Table 53 Europe: Latent Tb Testing Market For Other Applications,

By Country, 2022–2029 (Usd Million)

Table 54 Asia Pacific: Latent Tb Testing Market For Other Applications,

By Country, 2022–2029 (Usd Million)

Table 55 Latin America: Latent Tb Testing Market For Other Applications,

By Country, 2022–2029 (Usd Million)

Table 56 Middle East & Africa: Latent Tb Testing Market For Other Applications, By Country, 2022–2029 (Usd Million)

Table 57 Latent Tb Testing Market, By End User, 2022–2029 (Usd Million)

Table 58 Latent Tb Testing Market For Diagnostic Laboratories, By Region, 2022–2029 (Usd Million)

Table 59 North America: Latent Tb Testing Market For Diagnostic Laboratories, By Country, 2022–2029 (Usd Million)

Table 60 Europe: Latent Tb Testing Market For Diagnostic Laboratories,

By Country, 2022–2029 (Usd Million)

Table 61 Asia Pacific: Latent Tb Testing Market For Diagnostic Laboratories,

By Country, 2022–2029 (Usd Million)

Table 62 Latin America: Latent Tb Testing Market For Diagnostic Laboratories, By Country, 2022–2029 (Usd Million)

Table 63 Middle East & Africa: Latent Tb Testing Market For Diagnostic Laboratories, By Country, 2022–2029 (Usd Million)

Table 64 Us: Number Of Community Hospitals, 2020 –vs 2021

Table 65 Latent Tb Testing Market For Hospitals & Clinics, By Region,

2022–2029 (Usd Million)

Table 66 North America: Latent Tb Testing Market For Hospitals & Clinics,

By Country, 2022–2029 (Usd Million)

Table 67 Europe: Latent Tb Testing Market For Hospitals & Clinics, By Country, 2022–2029 (Usd Million)

Table 68 Asia Pacific: Latent Tb Testing Market For Hospitals & Clinics,

By Country, 2022–2029 (Usd Million)

Table 69 Latin America: Latent Tb Testing Market For Hospitals & Clinics,

By Country, 2022–2029 (Usd Million)

Table 70 Middle East & Africa: Latent Tb Testing Market For Hospitals & Clinics, By Country, 2022–2029 (Usd Million)

Table 71 Latent Tb Testing Market For Academic & Research Institutes,

By Region, 2022–2029 (Usd Million)

Table 72 North America: Latent Tb Testing Market For Academic & Research Institutes, By Country, 2022–2029 (Usd Million)

Table 73 Europe: Latent Tb Testing Market For Academic & Research Institutes, By Country, 2022–2029 (Usd Million)

Table 74 Asia Pacific: Latent Tb Testing Market For Academic & Research Institutes, By Country, 2022–2029 (Usd Million)

Table 75 Latin America: Latent Tb Testing Market For Academic & Research Institutes, By Country, 2022–2029 (Usd Million)

Table 76 Middle East & Africa: Latent Tb Testing Market For Academic & Research Institutes, By Country, 2022–2029 (Usd Million)

Table 77 Latent Tb Testing Market For Other End Users, By Region,

2022–2029 (Usd Million)

Table 78 North America: Latent Tb Testing Market For Other End Users,

By Country, 2022–2029 (Usd Million)

Table 79 Europe: Latent Tb Testing Market For Other End Users, By Country, 2022–2029 (Usd Million)

Table 80 Asia Pacific: Latent Tb Testing Market For Other End Users,

By Country, 2022–2029 (Usd Million)

Table 81 Latin America: Latent Tb Testing Market For Other End Users,

By Country, 2022–2029 (Usd Million)

Table 82 Middle East & Africa: Latent Tb Testing Market For Other End Users,

By Country, 2022–2029 (Usd Million)

Table 83 Latent Tb Testing Market, By Region, 2022–2029 (Usd Million)

Table 84 North America: Macroindicators For Latent Tb Testing Market

Table 85 North America: Latent Tb Testing Market, By Country,

2022–2029 (Usd Million)

Table 86 North America: Latent Tb Testing Market, By Test Type,

2022–2029 (Usd Million)

Table 87 North America: Latent Tb Testing Market, By Test Type,

2022–2029 (In Millions)

Table 88 North America: Latent Tb Testing Market, By Application,

2022–2029 (Usd Million)

Table 89 North America: Latent Tb Testing Market, By End User,

2022–2029 (Usd Million)

Table 90 Us: Main Tb/Ltbi Institutions

Table 91 Us: Latent Tb Testing Market, By Test Type, 2022–2029 (Usd Million)

Table 92 Us: Latent Tb Testing Market, By Test Type, 2022–2029 (In Millions)

Table 93 Us: Latent Tb Testing Market, By Application, 2022–2029 (Usd Million)

Table 94 Us: Latent Tb Testing Market, By End User, 2022–2029 (Usd Million)

Table 95 Canada: Main Tb/Ltbi Institutions

Table 96 Canada: Latent Tb Testing Market, By Test Type, 2022–2029 (Usd Million)

Table 97 Canada: Latent Tb Testing Market, By Test Type, 2022–2029 (In Millions)

Table 98 Canada: Latent Tb Testing Market, By Application,

2022–2029 (Usd Million)

Table 99 Canada: Latent Tb Testing Market, By End User, 2022–2029 (Usd Million)

Table 100 Asia Pacific: Macroeconomic Indicators For Latent Tb Testing Market

Table 101 Asia Pacific: Latent Tb Testing Market, By Country,

2022–2029 (Usd Million)

Table 102 Asia Pacific: Latent Tb Testing Market, By Test Type,

2022–2029 (Usd Million)

Table 103 Asia Pacific: Latent Tb Testing Market, By Test Type,

2022–2029 (In Millions)

Table 104 Asia Pacific: Latent Tb Testing Market, By Application,

2022–2029 (Usd Million)

Table 105 Asia Pacific: Latent Tb Testing Market, By End User,

2022–2029 (Usd Million)

Table 106 China: Main Tb/Ltbi Institutions

Table 107 China: Latent Tb Testing Market, By Test Type, 2022–2029 (Usd Million)

Table 108 China: Latent Tb Testing Market, By Test Type, 2022–2029 (In Millions)

Table 109 China: Latent Tb Testing Market, By Application,

2022–2029 (Usd Million)

Table 110 China: Latent Tb Testing Market, By End User, 2022–2029 (Usd Million)

Table 111 Japan: Main Tb/Ltbi Institutions

Table 112 Japan: Latent Tb Testing Market, By Test Type, 2022–2029 (Usd Million)

Table 113 Japan: Latent Tb Testing Market, By Test Type, 2022–2029 (In Millions)

Table 114 Japan: Latent Tb Testing Market, By Application,

2022–2029 (Usd Million)

Table 115 Japan: Latent Tb Testing Market, By End User, 2022–2029 (Usd Million)

Table 116 India: Main Tb/Ltbi Institutions

Table 117 India: Latent Tb Testing Market, By Test Type, 2022–2029 (Usd Million)

Table 118 India: Latent Tb Testing Market, By Test Type, 2022–2029 (In Millions)

Table 119 India: Latent Tb Testing Market, By Application, 2022–2029 (Usd Million)

Table 120 India: Latent Tb Testing Market, By End User, 2022–2029 (Usd Million)

Table 121 South Korea: Main Tb/Ltbi Institutions

Table 122 South Korea: Latent Tb Testing Market, By Test Type,

2022–2029 (Usd Million)

Table 123 South Korea: Latent Tb Testing Market, By Test Type,

2022–2029 (In Millions)

Table 124 South Korea: Latent Tb Testing Market, By Application,

2022–2029 (Usd Million)

Table 125 South Korea: Latent Tb Testing Market, By End User,

2022–2029 (Usd Million)

Table 126 Australia: Main Tb/Ltbi Institutions

Table 127 Australia: Latent Tb Testing Market, By Test Type,

2022–2029 (Usd Million)

Table 128 Australia: Latent Tb Testing Market, By Test Type,

2022–2029 (In Millions)

Table 129 Australia: Latent Tb Testing Market, By Application,

2022–2029 (Usd Million)

Table 130 Australia: Latent Tb Testing Market, By End User,

2022–2029 (Usd Million)

Table 131 Singapore: Main Tb/Ltbi Institutions

Table 132 Singapore: Latent Tb Testing Market, By Test Type,

2022–2029 (Usd Million)

Table 133 Singapore: Latent Tb Testing Market, By Test Type,

2022–2029 (In Millions)

Table 134 Singapore: Latent Tb Testing Market, By Application,

2022–2029 (Usd Million)

Table 135 Singapore: Latent Tb Testing Market, By End User,

2022–2029 (Usd Million)

Table 136 Rest Of Asia Pacific: Latent Tb Testing Market, By Test Type,

2022–2029 (Usd Million)

Table 137 Rest Of Asia Pacific: Latent Tb Testing Market, By Test Type,

2022–2029 (In Millions)

Table 138 Rest Of Asia Pacific: Latent Tb Testing Market, By Application,

2022–2029 (Usd Million)

Table 139 Rest Of Asia Pacific: Latent Tb Testing Market, By End User,

2022–2029 (Usd Million)

Table 140 Europe: Macroindicators For Latent Tb Testing Market

Table 141 Europe: Latent Tb Testing Market, By Country, 2022–2029 (Usd Million)

Table 142 Europe: Latent Tb Testing Market, By Test Type, 2022–2029 (Usd Million)

Table 143 Europe: Latent Tb Testing Market, By Test Type, 2022–2029 (In Millions)

Table 144 Europe: Latent Tb Testing Market, By Application,

2022–2029 (Usd Million)

Table 145 Europe: Latent Tb Testing Market, By End User, 2022–2029 (Usd Million)

Table 146 Uk: Main Tb/Ltbi Institutions

Table 147 Uk: Latent Tb Testing Market, By Test Type, 2022–2029 (Usd Million)

Table 148 Uk: Latent Tb Testing Market, By Test Type, 2022–2029 (In Millions)

Table 149 Uk: Latent Tb Testing Market, By Application, 2022–2029 (Usd Million)

Table 150 Uk: Latent Tb Testing Market, By End User, 2022–2029 (Usd Million)

Table 151 France: Main Tb/Ltbi Institutions

Table 152 France: Latent Tb Testing Market, By Test Type, 2022–2029 (Usd Million)

Table 153 France: Latent Tb Testing Market, By Test Type, 2022–2029 (In Millions)

Table 154 France: Latent Tb Testing Market, By Application,

2022–2029 (Usd Million)

Table 155 France: Latent Tb Testing Market, By End User, 2022–2029 (Usd Million)

Table 156 Germany: Main Tb/Ltbi Institutions

Table 157 Germany: Latent Tb Testing Market, By Test Type,

2022–2029 (Usd Million)

Table 158 Germany: Latent Tb Testing Market, By Test Type,

2022–2029 (In Millions)

Table 159 Germany: Latent Tb Testing Market, By Application,

2022–2029 (Usd Million)

Table 160 Germany: Latent Tb Testing Market, By End User,

2022–2029 (Usd Million)

Table 161 Spain: Main Tb/Ltbi Institutions

Table 162 Spain: Latent Tb Testing Market, By Test Type, 2022–2029 (Usd Million)

Table 163 Spain: Latent Tb Testing Market, By Test Type, 2022–2029 (In Millions)

Table 164 Spain: Latent Tb Testing Market, By Application, 2022–2029 (Usd Million)

Table 165 Spain: Latent Tb Testing Market, By End User, 2022–2029 (Usd Million)

Table 166 Italy: Main Tb/Ltbi Institutions

Table 167 Italy: Latent Tb Testing Market, By Test Type, 2022–2029 (Usd Million)

Table 168 Italy: Latent Tb Testing Market, By Test Type, 2022–2029 (In Millions)

Table 169 Italy: Latent Tb Testing Market, By Application, 2022–2029 (Usd Million)

Table 170 Italy: Latent Tb Testing Market, By End User, 2022–2029 (Usd Million)

Table 171 Belgium: Main Tb/Ltbi Institutions

Table 172 Belgium: Latent Tb Testing Market, By Test Type,

2022–2029 (Usd Million)

Table 173 Belgium: Latent Tb Testing Market, By Test Type, 2022–2029 (In Millions)

Table 174 Belgium: Latent Tb Testing Market, By Application,

2022–2029 (Usd Million)

Table 175 Belgium: Latent Tb Testing Market, By End User,

2022–2029 (Usd Million)

Table 176 Sweden: Latent Tb Testing Market, By Test Type,

2022–2029 (Usd Million)

Table 177 Sweden: Latent Tb Testing Market, By Test Type, 2022–2029 (In Millions)

Table 178 Sweden: Latent Tb Testing Market, By Application,

2022–2029 (Usd Million)

Table 179 Sweden: Latent Tb Testing Market, By End User,

2022–2029 (Usd Million)

Table 180 Denmark: Main Tb/Ltbi Institutions

Table 181 Denmark: Latent Tb Testing Market, By Test Type,

2022–2029 (Usd Million)

Table 182 Denmark: Latent Tb Testing Market, By Test Type,

2022–2029 (In Millions)

Table 183 Denmark: Latent Tb Testing Market, By Application,

2022–2029 (Usd Million)

Table 184 Denmark: Latent Tb Testing Market, By End User,

2022–2029 (Usd Million)

Table 185 Rest Of Europe: Latent Tb Testing Market, By Test Type,

2022–2029 (Usd Million)

Table 186 Rest Of Europe: Latent Tb Testing Market, By Test Type,

2022–2029 (In Millions)

Table 187 Rest Of Europe: Latent Tb Testing Market, By Application,

2022–2029 (Usd Million)

Table 188 Rest Of Europe: Latent Tb Testing Market, By End User,

2022–2029 (Usd Million)

Table 189 Latin America: Macroindicators For Latent Tb Testing Market

Table 190 Latin America: Latent Tb Testing Market, By Country,

2022–2029 (Usd Million)

Table 191 Latin America: Latent Tb Testing Market, By Test Type,

2022–2029 (Usd Million)

Table 192 Latin America: Latent Tb Testing Market, By Test Type,

2022–2029 (In Millions)

Table 193 Latin America: Latent Tb Testing Market, By Application,

2022–2029 (Usd Million)

Table 194 Latin America: Latent Tb Testing Market, By End User,

2022–2029 (Usd Million)

Table 195 Brazil: Main Tb/Ltbi Institutions

Table 196 Brazil: Latent Tb Testing Market, By Test Type, 2022–2029 (Usd Million)

Table 197 Brazil: Latent Tb Testing Market, By Test Type, 2022–2029 (In Millions)

Table 198 Brazil: Latent Tb Testing Market, By Application,

2022–2029 (Usd Million)

Table 199 Brazil: Latent Tb Testing Market, By End User, 2022–2029 (Usd Million)

Table 200 Mexico: Main Tb/Ltbi Institutions

Table 201 Mexico: Latent Tb Testing Market, By Test Type, 2022–2029 (Usd Million)

Table 202 Mexico: Latent Tb Testing Market, By Test Type, 2022–2029 (In Millions)

Table 203 Mexico: Latent Tb Testing Market, By Application,

2022–2029 (Usd Million)

Table 204 Mexico: Latent Tb Testing Market, By End User, 2022–2029 (Usd Million)

Table 205 Rest Of Latin America: Latent Tb Testing Market, By Test Type,

2022–2029 (Usd Million)

Table 206 Rest Of Latin America: Latent Tb Testing Market, By Test Type,

2022–2029 (In Millions)

Table 207 Rest Of Latin America: Latent Tb Testing Market, By Application,

2022–2029 (Usd Million)

Table 208 Rest Of Latin America: Latent Tb Testing Market, By End User,

2022–2029 (Usd Million)

Table 209 Middle East & Africa: Latent Tb Testing Market, By Country,

2022–2029 (Usd Million)

Table 210 Middle East & Africa: Latent Tb Testing Market, By Test Type,

2022–2029 (Usd Million)

Table 211 Middle East & Africa: Latent Tb Testing Market, By Test Type,

2022–2029 (In Millions)

Table 212 Middle East & Africa: Latent Tb Testing Market, By Application,

2022–2029 (Usd Million)

Table 213 Middle East & Africa: Latent Tb Testing Market, By End User,

2022–2029 (Usd Million)

Table 214 South Africa: Main Tb/Ltbi Institutions

Table 215 South Africa: Latent Tb Testing Market, By Test Type,

2022–2029 (Usd Million)

Table 216 South Africa: Latent Tb Testing Market, By Test Type,

2022–2029 (In Millions)

Table 217 South Africa: Latent Tb Testing Market, By Application,

2022–2029 (Usd Million)

Table 218 South Africa: Latent Tb Testing Market, By End User,

2022–2029 (Usd Million)

Table 219 Saudi Arabia: Latent Tb Testing Market, By Test Type,

2022–2029 (Usd Million)

Table 220 Saudi Arabia: Latent Tb Testing Market, By Test Type,

2022–2029 (In Millions)

Table 221 Saudi Arabia: Latent Tb Testing Market, By Application,

2022–2029 (Usd Million)

Table 222 Saudi Arabia: Latent Tb Testing Market, By End User,

2022–2029 (Usd Million)

Table 223 Uae: Latent Tb Testing Market, By Test Type, 2022–2029 (Usd Million)

Table 224 Uae: Latent Tb Testing Market, By Test Type, 2022–2029 (In Millions)

Table 225 Uae: Latent Tb Testing Market, By Application, 2022–2029 (Usd Million)

Table 226 Uae: Latent Tb Testing Market, By End User, 2022–2029 (Usd Million)

Table 227 Kuwait: Latent Tb Testing Market, By Test Type, 2022–2029 (Usd Million)

Table 228 Kuwait: Latent Tb Testing Market, By Test Type, 2022–2029 (In Millions)

Table 229 Kuwait: Latent Tb Testing Market, By Application,

2022–2029 (Usd Million)

Table 230 Kuwait: Latent Tb Testing Market, By End User, 2022–2029 (Usd Million)

Table 231 Rest Of Middle East & Africa: Latent Tb Testing Market, By Test Type, 2022–2029 (Usd Million)

Table 232 Rest Of Middle East & Africa: Latent Tb Testing Market, By Test Type, 2022–2029 (In Millions)

Table 233 Rest Of Middle East & Africa: Latent Tb Testing Market, By Application, 2022–2029 (Usd Million)

Table 234 Rest Of Middle East & Africa: Latent Tb Testing Market, By End User, 2022–2029 (Usd Million)

Table 235 Overview Of Strategies Deployed By Key Manufacturing Companies

Table 236 Latent Tb Testing Market: Degree Of Competition

Table 237 Latent Tb Testing Market: Test Type Footprint

Table 238 Latent Tb Testing Market: Application Footprint

Table 239 Latent Tb Testing Market: Region Footprint

Table 240 Latent Tb Testing Market: Detailed List Of Key Startups/Sme Players

Table 241 Latent Tb Testing Market: Competitive Benchmarking

Of Startup/Sme Players

Table 242 Latent Tb Testing Market: Product Launches,

January 2021–september 2024

Table 243 Latent Tb Testing Market: Deals, January 2021–september 2024

Table 244 Qiagen: Company Overview

Table 245 Qiagen: Products Offered

Table 246 Qiagen: Product Launches & Approvals, January 2021–september 2024

Table 247 Qiagen: Deals, January 2021–september 2024

Table 248 Qiagen: Expansions, January 2021–september 2024

Table 249 Revvity: Company Overview

Table 250 Revvity: Products Offered

Table 251 Revvity: Product Launches & Approvals, January 2021–september 2024

Table 252 Beijing Wantai Biopharmaceutical: Company Overview

Table 253 Beijing Wantai Biopharmaceutical: Products Offered

Table 254 Sanofi: Company Overview

Table 255 Sanofi: Products Offered

Table 256 Endo: Company Overview

Table 257 Endo: Products Offered

Table 258 Biomérieux: Company Overview

Table 259 Biomérieux: Products Offered

Table 260 Biomérieux: Product Approvals, January 2021–september 2024

Table 261 Sd Biosensor: Company Overview

Table 262 Sd Biosensor: Products Offered

Table 263 Sd Biosensor: Deals, January 2021–september 2024

Table 264 Lionex Gmbh: Company Overview

Table 265 Lionex Gmbh: Products Offered

Table 266 Serum Institute Of India: Company Overview

Table 267 Serum Institute Of India: Products Offered

Table 268 Arkray: Company Overview

Table 269 Arkray: Products Offered

Table 270 Arkray: Expansions, January 2021–september 2024

Figures List

Figure 1 Latent Tb Testing Market: Research Design

Figure 2 Bottom-up Approach: Company Revenue Estimation Approach

Figure 3 Cagr Projections: Supply-side Analysis

Figure 4 Latent Tb Testing Market: Top-down Approach

Figure 5 Latent Tb Testing Market: Data Triangulation

Figure 6 Latent Tb Testing Market: Study Assumptions

Figure 7 Latent Tb Testing Market, By Test Type, 2024 Vs. 2029 (Usd Million)

Figure 8 Latent Tb Testing Market, By Application, 2024 Vs. 2029 (Usd Million)

Figure 9 Latent Tb Testing Market, By End User, 2024 Vs. 2029 (Usd Million)

Figure 10 Latent Tb Testing Market, By Region, 2024 Vs. 2029 (Usd Million)

Figure 11 Increasing Prevalence Of Latent Tb And Growing Financial

Support For Tb Control To Drive Market

Figure 12 Igra Will Continue To Dominate Market Till 2029

Figure 13 People Living With Hiv Segment To Hold Largest Market Share

Figure 14 Diagnostic Laboratories Segment To Retain Dominant

Market Share Till 2029

Figure 15 Asia Pacific To Register Highest Growth

Figure 16 Latent Tb Testing Market: Drivers, Restraints,

Opportunities, And Challenges

Figure 17 Patent Analysis For Latent Tb Tests (January 2014–december 2023)

Figure 18 Value Chain Analysis: Major Value Added During Manufacturing And Assembly Phases

Figure 19 Latent Tb Testing Market: Supply Chain Analysis

Figure 20 Latent Tb Testing Market: Ecosystem Analysis

Figure 21 Latent Tb Testing Market: Porter’s Five Forces Analysis

Figure 22 Influence Of Stakeholders On Buying Process Of Latent Tb Tests

Figure 23 Key Buying Criteria For Latent Tb Tests

Figure 24 Trends/Disruptions Impacting Customer Business

Figure 25 Deals And Funding In Latent Tb Testing Market

Figure 26 Market Potential Of Ai To Enhance R&D In Latent Tb Testing Market

Figure 27 North America: Latent Tb Testing Market Snapshot

Figure 28 Asia Pacific: Latent Tb Testing Market Snapshot

Figure 29 Revenue Analysis Of Key Players In Latent Tb Testing Market

(2021–2023)

Figure 30 Market Share Analysis Of Key Players In Latent Tb

Testing Market (2023)

Figure 31 North America: Market Share Analysis Of Key Players (2023)

Figure 32 Europe: Market Share Analysis Of Key Players (2023)

Figure 33 Asia Pacific: Market Share Analysis Of Key Players (2023)

Figure 34 Latent Tb Testing Market: Company Evaluation Matrix

(Key Players), 2023

Figure 35 Latent Tb Testing Market: Company Footprint

Figure 36 Latent Tb Testing Market: Company Evaluation Matrix

(Startups/Smes), 2023

Figure 37 Ev/Ebitda Of Key Vendors

Figure 38 Year-to-date (Ytd) Price Total Return And 5-year Stock Beta Of Key Vendors

Figure 39 Brand Comparison For Igra

Figure 40 Qiagen: Company Snapshot (2023)

Figure 41 Revvity: Company Snapshot (2023)

Figure 42 Beijing Wantai Biopharmaceutical: Company Snapshot (2023)

Figure 43 Sanofi: Company Snapshot (2023)

Figure 44 Endo: Company Snapshot (2023)

Figure 45 Biomérieux: Company Snapshot (2023)

Figure 46 Sd Biosensor: Company Snapshot (2023)